Cibus Global LLC Total Liabilities

Latest as of June 2026: $298.64 Million USD

Cibus Global LLC total liabilities. Based on the latest financial reports, Cibus Global LLC (CBUS) has total liabilities worth $298.64 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Cibus Global LLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Cibus Global LLC (2015–2025)

Total liabilities of Cibus Global LLC from 2015 to 2025. This chart illustrates how Cibus Global LLC's total liabilities have evolved over time, based on quarterly financial data.

Cibus Global LLC Competitors by Total Liabilities

The table below lists competitors of Cibus Global LLC ranked by their total liabilities.

Company Country Total Liabilities
MIC Electronics Limited
NSE:MICEL
India Rs1.37 Billion
Nicola Mining Inc. American Depositary Shares
NASDAQ:NICM
USA $15.95 Million
Beazley plc
LSE:BEZ
UK GBX11.42 Billion
Bundamedik Tbk PT
JK:BMHS
Indonesia Rp1.62 Trillion
Urbas Grupo Financiero SA
MC:UBS
Spain €415.90 Million
AptaBio Therapeutics Inc
KQ:293780
Korea ₩22.51 Billion
M&G Plc
LSE:MNG
UK GBX192.29 Billion
Y.C.C. Parts MFG Co Ltd
TW:1339
Taiwan NT$1.15 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Cibus Global LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cibus Global LLC balance sheet assets.

Liquidity & Leverage Metrics

Cibus Global LLC Total Liabilities Ratios Explained

Cibus Global LLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.62 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 20.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.95 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cibus Global LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cibus Global LLC (2015–2025)

The table below shows the annual total liabilities of Cibus Global LLC from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $283.22 Million +12.28%
2024-12-31 $252.24 Million +22.38%
2023-12-31 $206.12 Million +1257.10%
2022-12-31 $15.19 Million -34.14%
2021-12-31 $23.06 Million -12.82%
2020-12-31 $26.45 Million +3.37%
2019-12-31 $25.59 Million +0.77%
2018-12-31 $25.39 Million +72.85%
2017-12-31 $14.69 Million +319.26%
2016-12-31 $3.50 Million +101.61%
2015-12-31 $1.74 Million --

About Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$94.77 Million
Market Cap Rank
#19216 Global
#4437 in USA
Share Price
$1.24
Change (1 day)
+8.77%
52-Week Range
$1.14 - $4.05
All Time High
$1574.00
About

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more